These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7016344)

  • 1. Differential effects of prostaglandins on the antitumor activity of normal and BCG-activated macrophages.
    McCarthy ME; Zwilling BS
    Cell Immunol; 1981 May; 60(1):91-9. PubMed ID: 7016344
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostaglandin regulation of macrophage function: effect of endogenous and exogenous prostaglandins.
    Snider ME; Fertel RH; Zwilling BS
    Cell Immunol; 1982 Dec; 74(2):234-42. PubMed ID: 6962757
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandin synthesis inhibitors potentiate the BCG-induced augmentation of natural killer cell activity.
    Tracey DE; Adkinson NF
    J Immunol; 1980 Jul; 125(1):136-41. PubMed ID: 6991599
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostaglandins as modulators of macrophage development from bone marrow.
    Razin E; Rivnay B; Globerson A
    J Reticuloendothel Soc; 1981 Oct; 30(4):239-46. PubMed ID: 6947086
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of prostaglandins in the development of macrophages from bone marrow cells.
    Razin E; Razin M; Lohmann-Matthes ML
    J Reticuloendothel Soc; 1980 Apr; 27(4):377-82. PubMed ID: 7373607
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of prostaglandins on phagocytosis of sheep erythrocytes by mouse peritoneal macrophages.
    Razin E; Bauminger S; Globerson A
    J Reticuloendothel Soc; 1978 Apr; 23(4):237-42. PubMed ID: 671419
    [No Abstract]   [Full Text] [Related]  

  • 7. Involvement of prostaglandin E1 in delayed-type hypersensitivity suppression induced with live Mycobacterium bovis BCG.
    Kato K; Yamamoto K
    Infect Immun; 1982 Apr; 36(1):426-9. PubMed ID: 7042574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCG-activated macrophages: comparison as effectors in direct tumor-cell cytotoxicity and antibody dependent cell-mediated cytotoxicity.
    Adams DO; Koren HS
    Adv Exp Med Biol; 1979; 121B():195-201. PubMed ID: 397747
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of murine natural killer cell activity by prostaglandins.
    Brunda MJ; Herberman RB; Holden HT
    J Immunol; 1980 Jun; 124(6):2682-7. PubMed ID: 6154736
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series.
    Schultz RM; Pavlidis NA; Stylos WA; Chirigos MA
    Science; 1978 Oct; 202(4365):320-1. PubMed ID: 694537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum.
    Tomecki J; Sukiennik J; Kordowiak A
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the antibody-dependent cell-mediated cytotoxicity (ADCC) of thioglycollate-stimulated and BCG-activated peritoneal macrophages.
    Koren HS; Anderson SJ; Adams DO
    Cell Immunol; 1981 Jan; 57(1):51-61. PubMed ID: 7011574
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for a multistep mechanism of cytolysis by BCG-activated macrophages: the interrelationship between the capacity for cytolysis, target binding, and secretion of cytolytic factor.
    Adams DO; Marino PA
    J Immunol; 1981 Mar; 126(3):981-7. PubMed ID: 7007505
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostaglandin and thromboxane synthesis in a pure macrophage population and the inhibition, by E-type prostaglandins, of chemiluminescence.
    Weidemann MJ; Peskar BA; Wrogemann K; Rietschel ET; Staudinger H; Fischer H
    FEBS Lett; 1978 May; 89(1):136-40. PubMed ID: 350620
    [No Abstract]   [Full Text] [Related]  

  • 15. Production of arachidonic acid metabolites by operationally defined macrophage subsets.
    Snider ME; Fertel RH; Zwilling BS
    Prostaglandins; 1983 Apr; 25(4):491-501. PubMed ID: 6410458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prostaglandin E1 on the level of cAMP in bone marrow macrophages. Inhibition of phagocytosis and cell shape changes.
    Oropeza-Rendon RL; Bauer HC; Fischer H
    J Immunopharmacol; 1980; 2(1):133-47. PubMed ID: 6256452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin-mediated suppression of macrophage phagocytosis of Listeria monocytogenes.
    Hutchison DL; Myers RL
    Cell Immunol; 1987 Nov; 110(1):68-76. PubMed ID: 3119229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of macrophages for tumor cell cytotoxicity: identification of indomethacin sensitive and insensitive pathways.
    Drysdale BE; Shin HS
    J Immunol; 1981 Aug; 127(2):760-5. PubMed ID: 6788847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The possible role of prostaglandins in mediating immune suppression by nonspecific T suppressor cells.
    Fulton AM; Levy JG
    Cell Immunol; 1980 Jun; 52(1):29-37. PubMed ID: 6446407
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo fertilization of rabbit oocytes exposed to continuous intrauterine administration of prostaglandin E2, prostaglandin F2 alpha, and indomethacin.
    Dören M; Schlegel W; Schneider HP
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1122-4. PubMed ID: 2960157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.